ANY PATIENT TREATED WITH MB-105

Clinical trials for ANY PATIENT TREATED WITH MB-105 explained in plain language.

Never miss a new study

Get alerted when new ANY PATIENT TREATED WITH MB-105 trials appear

Sign up with your email to follow new studies for ANY PATIENT TREATED WITH MB-105, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

15-Year watch begins for patients who received experimental treatment

Disease control Not yet recruiting

This study is a required long-term follow-up for patients who have already received the treatment MB-105 in a previous trial. It will monitor 40 patients for 15 years to check for any long-term side effects and to see how well the treatment continues to work over time. The main g…

Matched conditions: ANY PATIENT TREATED WITH MB-105

Sponsor: March Biosciences Inc • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

ANY PATIENT TREATED WITH MB-105

Get alerted when new ANY PATIENT TREATED WITH MB-105 trials appear

15-Year watch begins for patients who received experimental treatment